. Bronchial vasodilatory response to ionic and nonionic contrast media. J. Appl. Physiol. 82(3): 841-845, 1997.-It has recently been shown that bronchial arterial injection of conventional contrast medium causes a significant increase in bronchial blood flow (Q br) and that this response is partially attenuated after infusion of N v -nitro-Larginine (L-NNA). However, the precise mechanism for this increase in Q br is unknown. In this study we examined the effect of bronchial arterial injection of conventional ionic as well as nonionic contrast media. We measured Q br in nine anesthetized, ventilated, open-chest sheep. Q br was recorded before (baseline) and at the peak response to injection of 0.5 ml of either 0.9% saline (control; isosmolar with plasma), Omnipaque 300 (iohexol; nonionic), Conray 66 (sodium iothalamate; ionic), or 50% dextrose (viscous control). Measurements were made during a control period, after infusion of the a-agonist phenylephrine (5 3 10 26 to 5 3 10 27 M), and after bronchial arterial infusion of L-NNA (10 22 M). The results were as follows: bronchial arterial injection of saline, Omnipaque, Conray, and dextrose caused an increase in Q br (P , 0.05). During the control period, increases in peak Q br on injection of saline, Omnipaque, Conray, and dextrose were 55 6 29, 112 6 62, 280 6 99, and 388 6 125% of baseline, respectively. Bronchial arterial infusion of L-NNA lowered baseline Q br and partially attenuated the response to injection of saline, Omnipaque, and Conray (P , 0.05). Phenylephrine, in doses that decreased baseline Q br to the same extent as did L-NNA, did not attenuate the bronchial vasodilation. There was a linear relationship between osmolality and the percentage increase in bronchial blood flow. We conclude that an osmolar stress is the trigger for the contrast-induced bronchial vasodilation and that the response is partially mediated by endothelial release of nitric oxide.
OUR LABORATORY has recently shown that conventional ionic contrast medium (66% diatrizoate meglumine and 10% diatrizoate sodium; MD-76) causes vasodilation of the bronchial vasculature in sheep and that this response was significantly attenuated after infusion of N v -nitro-L-arginine (L-NNA), a competitive inhibitor of nitric oxide (NO) synthase, suggesting that endothelium-derived NO partially mediates the contrastinduced bronchial vascular dilation (1) . The precise mechanism by which the contrast medium produced this vasodilatory response was not determined. It is possible that it may have been related to perturbations in the flow profile because it is known that shear stress can stimulate the generation of NO by the endothelium (13, 16) . Bronchial arterial injection of a high-density high-viscosity agent, such as MD-76, could subject the endothelium to a significant increase in shear stress. If this were the mechanism triggering the release of NO, then nonionic contrast media, which are also very viscous, should also induce bronchial vasodilation. It is also possible that the vasodilatory response is directly related to the osmolality of the contrast medium; Smith et al. (19) have reported an increasing vasodilatory response in the microcirculation of rat tracheae to superfusion solutions of increasing osmolality.
In this study we have examined the effect of bronchial arterial injection of an ionic (Conray 66) and a nonionic contrast agent (Omnipaque 300) and a solution of intermediate viscosity but higher osmolality (50% dextrose). The contrast agents were selected on the basis of their different ionic properties, osmolality, and viscosities. (It is possible for a contrast medium to have a high-osmolality and low-ionic content if the solute does not dissociate. Similarly, ionic content and density are not related. Density reflects the concentration and atomic number of the solute.) The contrast agents used in this study are in widespread use throughout North America. We measured bronchial blood flow at baseline and after a bolus injection of these agents, and we repeated this protocol after bronchial arterial infusion of L-NNA to examine whether the changes in bronchial blood flow were mediated by NO.
MATERIALS AND METHODS
Surgical protocol. We studied nine Dorset-cross rams (25-30 kg) while they were in the supine position.
All studies were done according to the Canadian guidelines for the use and care of animals. Anesthesia was induced by intravenous injection of thiopental sodium (15-20 mg/kg), a tracheotomy tube was inserted, and the sheep were ventilated with 50% oxygen and air at a tidal volume of 12-15 ml/kg and a rate of ,15 breaths/min. Anesthesia was maintained by using a continuous intravenous infusion of thiopental sodium (5-10 mg · kg 21 ·h 21 ).
A catheter was inserted in the left carotid artery for measurement of systemic arterial blood pressure and to obtain blood samples to measure arterial blood-gas tensions. With use of fluoroscopy, a thermistor-tipped triple-lumen catheter was inserted into the right jugular vein and advanced to the pulmonary artery for measurement of pulmonary arterial and wedge pressures and of cardiac output by using the thermodilution technique; a double-lumen catheter was placed in the superior vena cava for continuous infusion of the anesthetic (proximal port) and administration of intravenous fluids and drugs (distal port), as necessary. All vascular pressures were referenced to the level of the left atrium.
Sheep were paralyzed by intravenous injection of 2 mg pancuronium bromide. The chest was then opened by a left thoracotomy incision between the fifth and sixth ribs, and 3 cmH 2 O of positive end-expiratory pressure were applied. To measure bronchial arterial blood flow, the bronchial artery was carefully exposed and a 2-mm flow probe (Transonic Systems, Ithaca, NY) was placed around the bronchial esophageal artery. The probe was then connected to the flowmeter, and bronchial blood flow was recorded by using a low-pass filter setting of 10 Hz. A 5-Fr cobra catheter was introduced into the right femoral artery. With use of fluoroscopy and injection of small amounts of radiocontrast material, the catheter was advanced so that the tip was in the orifice of the bronchial esophageal artery. Bronchial blood flow was recorded continuously during placement of the cobra catheter to ensure that it was situated so that it did not alter the blood flow. To prevent clotting in the cobra catheter and the bronchial artery, heparin (4,000 U) was given intravenously, and this was supplemented by the administration of 1,000 U every 2 h. All pressure and flow tracings were displayed continuously on a video display unit and were recorded as necessary by using a digital recording system (Raytech, Vancouver, BC).
As soon as an intravenous line was in place, ibuprofen (15 mg/kg) was administered to block any vasodilatory effects of prostaglandins; after completion of surgery, an intravenous bolus of the b-adrenergic blocker propranolol (2 mg/kg) was administered, followed by a continuous infusion of 20 µg·kg 21 · min 21 . To avert vagally mediated reflexes from affecting the bronchial vascular response to the injected agents, a bilateral vagotomy was carried out.
Experimental protocol. After the surgery and when the sheep were stable, we recorded baseline measurements of arterial blood-gas tensions, cardiac output, systemic arterial blood pressure, and pulmonary arterial pressure. Bronchial blood flow was recorded during three different experimental conditions: 1) control, 2) bronchial arterial infusion of the a-agonist phenylephrine, and 3) bronchial arterial infusion of the NO synthase inhibitor L-NNA.
The reason that phenylephrine was given in six of the nine sheep was because we knew from results of a previous study (4) that infusion of L-NNA produces a consistent decrease in baseline bronchial blood flow. Therefore, to test whether simple vasoconstriction with a contractile agonist would attenuate the vasodilatory response to contrast agents, we gave sufficient phenylephrine to decrease bronchial blood flow by the same amount as we anticipated would occur on infusion of L-NNA. It usually took 5-10 min of infusion of phenylephrine to reduce bronchial blood flow to this anticipated level (,50% of the baseline value). As previously described (1), L-NNA was infused for 20 min via the cobra catheter into the bronchial artery. The infusion rate was set at one-tenth of the bronchial blood flow and adjusted at 5-min intervals as bronchial blood flow decreased. Contrast agents were injected after 20 min of infusion of L-NNA.
During each of these periods we recorded changes in bronchial blood flow in response to bronchial arterial injection of four different agents: saline (0.5 mol/l); Omnipaque 300, a nonionic contrast agent (Sterling-Winthrop, Markham, ON); Conray 66, an ionic contrast agent (Mallinckrodt Medical, Pointe Claire, PQ); and 50% dextrose, a viscous nonionic agent.
These agents were administered in random order, and duplicate measurements of the response were made. The protocol was as follows. The cobra catheter was loaded with 0.5 ml of one of the agents (the dead space of the catheter was 0.7 ml), which was then infused into the bronchial artery by using a pump set at a rate of 2 ml/min. Between bolus injections, the bronchial artery was infused with one of three solutions: for period 1, the infusate was 0.5 mol/l saline; for period 2, it was phenylephrine (5 3 10 26 to 5 3 10 27 M); and for period 3, it was L-NNA (10 22 M). Recording of bronchial blood flow was started 15 s before injection of each bolus (baseline) and continued until bronchial blood flow had returned to its baseline value (usually ,1 min). At the end of the experiment, the sheep were deeply anesthetized and killed by intravascular injection of saturated potassium chloride.
The relative physicochemical properties of saline, Omnipaque, Conray, and 50% dextrose were measured. Specifically, we measured density, pH, relative viscosity, and osmolality. Density was measured by weighing, in duplicate, 1 ml of each of the substances. The pH of each agent was measured by using a blood-gas analyzer (model ABL 30 acid-base analyzer, Radiometer, Copenhagen, Denmark). The viscosity was measured against water at 37°C by using an Ostwald viscosimeter, where the viscosity of water 5 1. The osmolality was measured by freezing-point depression by using a microosmometer (model 3MO, Advanced Instruments, Norwood, MA).
Data analysis. To test whether a bolus injection increased blood flow, baseline and peak bronchial blood flow (ml/min) were analyzed by using a one-tailed paired t-test. A two-way analysis of variance was used to compare changes in baseline bronchial blood flow caused by infusion of L-NNA and phenylephrine. After application of a square-root transformation of the data, the absolute and percent increases in blood flow produced by the four injectates during the three experimental periods were analyzed by using a repeated-measures analysis of variance with one repeating factor and one grouping factor while blocking on sheep. The sequential rejective Bonferroni procedure was used to correct for multiple comparisons and multiple t-tests. The correlation between the viscosity and the osmolality of the injectate and the resultant percent increase in bronchial blood flow were examined by using a Pearson correlation. A corrected P value , 0.05 was taken to be significant.
RESULTS
There were no differences in baseline values of bronchial blood flow before the injection of saline, Omnipaque, Conray, or 50% dextrose for each of the three experimental periods. Infusion of phenylephrine and L-NNA resulted in a reduction in baseline bronchial blood flow of 53 6 0.2 (P , 0.001) and 37 6 0.3% (P , 0.001), respectively (Table 1) . There was no difference in the baseline blood flow during the L-NNA and phenylephrine periods (P 5 0.54).
Bronchial arterial injection of saline, Omnipaque, Conray, and 50% dextrose produced an increase in bronchial blood flow (ml/min) irrespective of the experimental period (P , 0.01 for all comparisons). There were, however, considerable differences in the magnitude of the increase depending on which of the four agents was injected and on the experimental period. The absolute increase in bronchial blood flow was significantly less during the L-NNA period relative to the control period for all four agents. The absolute increase during the L-NNA period was less than during the phenylephrine period. The percent increases in bronchial arterial blood flow for individual sheep are shown in Table 2 , and the mean values (6 SD) for the percent increases are shown in Table 3 . The percent increases in bronchial blood flow were less during infusion of L-NNA (period 3) than during infusion of saline (control, period 1) or phenylephrine (period 2) for all four agents (saline, Omnipaque, Conray, and dextrose). The percent increases in bronchial blood flow caused by injection of each of the four agents during phenylephrine infusion were greater than during the control period and during the L-NNA period.
The percent increase in bronchial blood flow induced by injection of each of the four agents was always in the same order, irrespective of the experimental period. Fifty percent dextrose induced the greatest increase in bronchial blood flow, followed by Conray and then Omnipaqe, and lastly 0.9% saline (P , 0.05; Tables 2  and 3 ).
Arterial blood-gas tensions and hemodynamics were within normal physiological limits throughout the study. Values (means 6 SE) are shown in Table 4 .
Results of the physico-chemical analyses for saline, Omnipaque, Conray, and 50% dextrose are shown in Table 5 (normal serum osmolality is 285-295 mosmol/ kg). Also included for comparison is the percent increase from baseline in bronchial blood flow in response to injection of each of the four agents (during period 1, saline infusion). There was a linear relationship between osmolality and the percent increase in bronchial blood flow (r 5 0.997, P , 0.5). None of the other physico-chemical properties was related to the changes in bronchial blood flow.
DISCUSSION
The results from this study show that bronchial arterial injection of any one of the four agents produced a transient increase in bronchial blood flow. The absolute magnitude of this increase, however, differed considerably between agents: saline and Omnipaque elicited somewhat less than a doubling of bronchial blood flow, whereas injection of Conray elicited a three-to fivefold increase; the greatest increase (4.5-to 9-fold) was produced by 50% dextrose.
Infusion of L-NNA partially attenuated the increase in bronchial blood flow produced by injection of each one of the four agents, suggesting that vasodilation was caused in part by endothelial release of NO. The attenuation of the vasodilatory response was not attributable to an increase in baseline bronchial vascular tone because infusion of the a 1 -agonist phenylephrine, which lowered the baseline bronchial blood flow by an equivalent amount as did infusion of L-NNA, resulted in a greater percent increase in bronchial blood flow. It is difficult to compare the magnitude of vascular dilation in response to a stimulus before and after an intervention that changes baseline vascular caliber. A constricted vessel has a greater capability of dilating yet may resist the smooth muscle-relaxant effect of a mediator. At constant perfusion pressure, as was the case in our study (aortic pressure was not effected during the bolus injection and was constant during the three experimental periods), the same degree of smooth muscle relaxation may produce different degrees of change in flow because of the alinear relationship between vascular diameter and flow. Therefore, it was impossible to implicate a role for NO release to explain the response to contrast and hyperosmolar boluses by merely comparing the control and post-L-NNA responses. However, the fact that the response was attenuated, relative to that during comparable degrees of vasoconstriction produced by phenylephrine, is strong evidence that NO has a role in this response. A similar pattern of response has been shown in the bronchial vasculature for the vasodilation caused by acetylcholine, which is know to release endothelial NO (17) .
Because there is evidence to suggest that NO and prostaglandins are coreleased (8), and because vasodila- Values are given in %. http://jap.physiology.org/ tory prostaglandins can be released in response to surgery (3), we administered a blocking dose of ibuprofen at the start of the study, making it unlikely that vasodilatory prostaglandins were participating in the bronchial vasodilatory response. Similarly, to prevent a confounding effect of bronchial vasodilation due to b-adrenergic stimulation, a continuous infusion of the nonselective b-adrenergic antagonist propranolol was administered. We can only speculate as to why the bronchial vasodilatory response was not completely attenuated after administration of L-NNA, cyclooxygenase blockers, and a b-adrenergic blocker. It could be that insufficient L-NNA was given or that other vasodilatory mediators, such as endothelium-derived hyperpolarizing factor, were present (20) .
The vasodilatory effect of contrast media on other vascular beds has been well documented (4) (5) (6) 10) . However, the precise mechanism for this response remains unclear. Although the different effects of ionic and nonionic contrast agents have often been attributed to differences in osmolality (6, 10) , results from some studies suggest that other factors such as viscosity, pH, chemotoxicity, and different metabolic effects may contribute to the vasodilatory response (2, 5, 14, 15) . It is recognized that endothelial shear stress is an important stimulus for NO release. Because endothelial shear should be directly related to viscosity, we injected agents in which osmolality and viscosity varied independently to test which of the physicochemical characteristics was most important.
A vasodilatory response to osmolar stimuli in the airway vasculature and its attenuation by an NO synthase inhibitor were reported in a recent study by Smith et al. (19) . They showed that hypertonic solutions superfused over the tracheal epithelium of anesthetized rats resulted in vasodilation of the underlying mucosal microcirculation; vasodilation increased with each increase in osmolality, and at 300% of control osmolality, leakage of fluorescein isothiocyanate-labeled dextran from microcirculation to interstitium was observed. Addition of the competitive substrate for NO synthase, nitro-L-arginine methyl ester, inhibited the tracheal vascular dilation, and addition of L-arginine restored the dilatory response.
In harmony with the findings of Smith et al. (19) , our results support the idea that osmolar challenge causes release of NO. We found a linear relationship between osmolality and changes in bronchial blood flow, and no relationship between blood flow and viscosity, suggesting that the vasodilatory response in the bronchial vasculature is mainly induced by the high osmolality.
Although it is not clear how changes in osmolality lead to generation of NO, a possible explanation for the series of events leading to release of NO when contrast agent is injected intra-arterially is illustrated diagramatically in Fig 1. Bronchial vascular injection of a hyperosmolar bolus could draw fluid into the vessel lumen by osmosis; the resulting increased flow could increase endothelial shear, causing release of NO. The increased release of NO causes vasodilation and a decrease in shear stress. Vasodilatory mediators are released from the endothelium because of transient increase in endothelial shear stress in a variety of vascular beds (7, 9, 12, 13) . Results from some studies suggest that the dilation in response to increased shear stress is caused, at least partially, by endothelial release of NO (8, 16) . However, the fact that the change in blood flow is more closely related to osmolality than to viscosity suggests that additional mechanisms may be contributing to the vasodilation. The passage of a hyperosmolar bolus through the vasculature may cause transient dehydration and consequent deformation of endothelial cells; the endothelial deformation could result in an additional stimulus for release of NO. It should be noted that the mechanism described above cannot explain the results of Smith et al. (19) because their osmolar stimulus was extravascular. In summary, results from this study show that conventional ionic and nonionic intravenous contrast media cause vasodilation of the bronchial vasculature and that the magnitude of the response is related to the osmolality of the media. The vasodilation is, in part, due to a local release of NO. Angiographers should be aware of this effect, especially the profound effect of the high-osmolar contrast media. Bronchial angiography is often used to locate the site of hemorrhage in patients who have hemoptysis; one would anticipate that there could be an increase in the rate of hemorrhage at the time of injection. Although this might make a slowly bleeding vessel more visible, it could also aggravate the hemoptysis. The results also raise the intriguing possibility of using intra-arterial infusion of L-NNA as a therapeutic intervention. Besides decreasing blood flow, NO synthase inhibitors have been shown to increase platelet adhesion (11) and could aid in the treatment of hemoptysis by encouraging thrombosis in the bronchial artery.
